A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy

BMJ Case Rep. 2012 Sep 3:2012:bcr2012006970. doi: 10.1136/bcr-2012-006970.

Abstract

A 45-year-old Caucasian female with diagnosis of central serous chorioretinopathy (CSCR) did not improve on conventional observational approach. She was not willing to proceed with photocoagulation or photodynamic therapy. An unconventional approach of topical anti-inflammatory (ketorolac, dexamethasone and hydrocortisone) preparation was prescribed. The course of her CSCR responded well on this unconventional treatment, but relapsed on cessation or tapering of treatment. After 18 weeks of treatment with a gradual taper, her condition resolved. The present case highlights an alternative but unconventional treatment of CSCR with prolonged use of anti-inflammatories.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Central Serous Chorioretinopathy / diagnosis
  • Central Serous Chorioretinopathy / drug therapy*
  • Dexamethasone / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Humans
  • Hydrocortisone / administration & dosage*
  • Ketorolac / administration & dosage*
  • Middle Aged
  • Ophthalmic Solutions
  • Recurrence
  • Tomography, Optical Coherence
  • Visual Acuity / drug effects

Substances

  • Anti-Inflammatory Agents
  • Ophthalmic Solutions
  • Dexamethasone
  • Hydrocortisone
  • Ketorolac